Dr. Danko Martincic, MD
Claim this profileGSK Investigational Site
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
3 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Danko Martincic, MD is currently running
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
Belantamab Mafodotin + Pd vs Bortezomib + Pd
for Multiple Myeloma
This study will evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple myeloma (RRMM).
Recruiting2 awards Phase 310 criteria
More about Danko Martincic, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Danko Martincic, MD has experience with
- Belantamab Mafodotin
- Bortezomib
- Dexamethasone
- Pomalidomide
- Trilaciclib
- Cisplatin
Breakdown of trials Danko Martincic, MD has run
Plasma Cell Neoplasms
Bladder Cancer
Myelosuppression
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Danko Martincic, MD specialize in?
Danko Martincic, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Danko Martincic, MD currently recruiting for clinical trials?
Yes, Danko Martincic, MD is currently recruiting for 2 clinical trials in Coeur d'Alene Idaho. If you're interested in participating, you should apply.
Are there any treatments that Danko Martincic, MD has studied deeply?
Yes, Danko Martincic, MD has studied treatments such as Belantamab mafodotin, Bortezomib, Dexamethasone.
What is the best way to schedule an appointment with Danko Martincic, MD?
Apply for one of the trials that Danko Martincic, MD is conducting.
What is the office address of Danko Martincic, MD?
The office of Danko Martincic, MD is located at: GSK Investigational Site, Coeur d'Alene, Idaho 83814 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.